The global fund to fight AIDS, tuberculosis and malaria: 10 Years on

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 14, Issue 1, 2014, Pages 54-57

  Hanefeld, Johanna ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Global fund; Global health; Health financing; Public private partnerships

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMERCIAL PHENOMENA; FINANCIAL MANAGEMENT; FUNDING; GOVERNMENT; HEALTH CARE; HUMAN; MALARIA; MEDICAL INFORMATION SYSTEM; PUBLIC-PRIVATE PARTNERSHIP; RESOURCE MANAGEMENT; REVIEW; TUBERCULOSIS;

GLOBAL FUND; GLOBAL HEALTH; HEALTH FINANCING; PUBLIC PRIVATE PARTNERSHIPS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DELIVERY OF HEALTH CARE; FINANCIAL SUPPORT; HUMANS; INTERNATIONAL COOPERATION; MALARIA; MODELS, ORGANIZATIONAL; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TUBERCULOSIS; WORLD HEALTH;

EID: 84896729062     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.14-1-54     Document Type: Review

References (31)

1. Brugha R, Walt G. A global health fund: a leap of faith? BMJ 2001;323:152-4.
2. Joint United Nations Programme on HIV/AIDS. Keeping the promise. Summary of the declaration of commitment on HIV/AIDS. United Nations General Assembly, Special Session on HIV/AIDS, 25-27 June 2001, New York. Geneva: UNAIDS, 2002.
3. GFATM. The Global Fund to Fight AIDS, Tuberculosis and Malaria: fourth replenishment (2014-2016). Update on Results and Impact. Geneva: GFATM, 2013.
4. Brugha R. Global health initiatives and public health policy. In: Heggenhougen K, Quah S (eds), International encyclopedia of public health. San Diego, CA: Academic Press, 2008:72-81.
5. Buse K, Walt G. Global public-private partnerships: part I - a new development in health? Bull World Health Org 2000;78:549-61.
6. Brugha R, Donoghue M, Starling M et al. The Global Fund: managing great expectations. Lancet 2004;364:95-100.
7. Hanefeld J. How have global health initiatives impacted on health equity? Promot Educ 2008;15:19-23.
8. Biesma RG, Brugha R, Harmer A et al. The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control. Health Policy Plan 2009;24:239-52.
9. Usher AD. Defrauding of the Global Fund gives Sweden cold feet. Lancet 2010;376:1631.
10. Supporting the Global Fund to fight fraud. Lancet 2011;377:440.
11. The future of the Global Fund. Lancet 2012;380:860.
12. Brown JC, Griekspoor W. Fraud at the Global Fund? A viewpoint. Int J Health Plann Manage 2013;28:138-43.
13. Moszynski P. Global Fund suspends new projects until 2014 because of lack of funding. BMJ 2011;343:d7755.
14. Sidibe M, Ramiah I, Buse K. The Global Fund at five: what next for universal access for HIV/AIDS, TB and malaria? J R Soc Med 2006;99:497-500.
15. Sherry J, Mookherji S, Ryan L. The five-year evaluation of the Global Fund to Fight AIDS, Tuberculosis, and Malaria: synthesis of study areas 1, 2 and 3. Geneva: Technical Evaluation Reference Group, 2009.
16. Cometto G, Ooms G, Starrs A, Zeitz P. A global fund for the health MDGs? Lancet 2009;373:1500-2.
17. Samb B, Evans T, Dybul M et al. An assessment of interactions between global health initiatives and country health systems. Lancet 2009;373:2137-69.
18. Hanefeld J. The impact of global health initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. AIDS Care 2010;22:93-102.
19. Hanefeld J, Musheke M. What impact do global health initiatives have on human resources for antiretroviral treatment roll-out? A qualitative policy analysis of implementation processes in Zambia. Hum Resour Health 2009;7:8.
20. Tragard A, Shrestha IB. System-wide effects of Global Fund investments in Nepal. Health Policy Plan 2010;25:i58-62.
21. Atun R, Pothapregada SK, Kwansah J et al. Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana. J Acquir Immune Defic Syndr 2011;57(suppl 2):S72-6.
22. Car J, Paljarvi T, Car M et al. Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review. JRSM Short Reports 2012;3:70.
23. Hafner T, Shiffman J. The emergence of global attention to health systems strengthening. Health Policy Plan 2013;28:41-50.
24. Piot P, Kazatchkine M, Dybul M, Lob-Levyt J. AIDS: lessons learnt and myths dispelled. Lancet 2009;374:260-3.
25. Kapilashrami A, O'Brien O. The Global Fund and the re-configuration and re-emergence of 'civil society': widening or closing the democratic deficit? Global Public Health 2012;7:437-51.
26. Caceres CF, Giron JM, Sandoval C et al. Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007. Glob Public Health 2010;Apr 13:1-19.
27. Usher AD. Mark Dybul appointed to lead the Global Fund. Lancet 2012;380:1803-4.
28. Global Fund to Fight AIDS, Tuberculosis and Malaria. The new funding model. Geneva: GFATM, 2013.
29. Aziz R. Obama 2014 budget: continued support for Global Fund, paired with PEPFAR cut leave Blueprint goals in question. Brussels: European IDS Treatment Group, 2013.
30. Gulland A. Germany donates €1bn to Global Fund to Fight Aids, Tuberculosis and Malaria. BMJ 2013;346:f566.
31. Palen J, El-Sadr W, Phoya A et al. PEPFAR, health system strengthening, and promoting sustainability and country ownership. J Acquir Immune Defic Syndr 2012;60:S113-9.